Drug intelligence / Profile preview

Lymphdiaral Basistropfen

Development stage: Phase 3
Lead developer: Pascoe Naturmedizin
Administration: Oral

Overview

Lymphdiaral Basistropfen is a fixed homeopathic remedy developed by Pascoe Pharmazeutische Praeparate GmbH. It is composed of multiple homeopathic ingredients including Calendula mother tincture, Condurango 2X, Phytolacca 2X, Carduus marianus 1X, Chelidonium 2X, Hydrastis mother tincture, Leptandra mother tincture, Taraxacum mother tincture, Echinacea mother tincture, Lycopodium 2X, Sanguinaria mother tincture, and Arsenicum album 8X. This remedy is being investigated for its efficacy and safety in the treatment of chronic low-back pain.

Brand names: Lymphdiaral Basistropfen
Other names: histidine decarboxylaseLymphdiaralHomoeopathic Drug Combination

Beyond the preview

Go deeper on Lymphdiaral Basistropfen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lymphdiaral Basistropfen.

Explore the full profile